)
Medifast (MED) investor relations material
Medifast Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Leadership transition announced: CEO to step down in June 2026, with the President expected to assume the role, ensuring continuity in strategy and execution.
The company is transitioning from a weight loss focus to a broader metabolic health strategy, launching new science-driven products and programs, with a new product line targeting metabolic health and visceral fat reduction to launch in the back half of 2026.
Coach productivity turned positive year-over-year in Q4 2025 for the first time since 2022, with a 6% increase and revenue per active earning coach rising to $4,664.
Strong cash position with no debt supports ongoing transformation and coach engagement initiatives.
Active earning coaches dropped 40.6% to 16,100, but a double-digit percentage achieved executive director rank in Q4, with highest retention since 2022.
Financial highlights
Q4 2025 revenue was $75.1 million, down 36.9% year-over-year, with full-year 2025 revenue totaling $385.8 million.
Net loss for Q4 was $18.1 million ($1.65 per diluted share), including a $12.1 million non-cash deferred tax valuation allowance; full-year net loss was $18.7 million ($1.70 per share).
Gross profit margin for Q4 2025 was 69.4%, down 470 basis points year-over-year, impacted by lower sales and a one-time restructuring charge.
SG&A expenses decreased 31.5% year-over-year to $59.9 million, but as a percentage of revenue increased to 79.8% due to loss of leverage and restructuring.
Ended 2025 with $167.3 million in cash and investments, no debt, and working capital at $158.7 million.
Outlook and guidance
Q1 2026 revenue expected between $65 million and $80 million, with loss per share between $0.15 and $0.70.
Full-year 2026 revenue guidance of $270 million to $300 million, with loss per share between $1.55 and $2.75.
Profitability improvements targeted to begin in Q4 2026, following new product launch, with further gains expected into 2027.
Working capital projected to remain above $140 million at year-end 2026.
Next Medifast earnings date
Next Medifast earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage